Effect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury.
The α7 neuronal nicotinic acetylcholine receptors (α7nAChRs) are essential for anti-inflammatory responses. The human-specific CHRFAM7A gene and its 2bp deletion polymorphism (Δ2bp variant) encodes a structurally-deficient α7nAChRs that may impact the anti-inflammatory function. We studied 45 spinal...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a386b81cf444528804f9e1a7194413f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4a386b81cf444528804f9e1a7194413f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4a386b81cf444528804f9e1a7194413f2021-11-25T05:54:17ZEffect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury.1932-620310.1371/journal.pone.0251110https://doaj.org/article/4a386b81cf444528804f9e1a7194413f2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0251110https://doaj.org/toc/1932-6203The α7 neuronal nicotinic acetylcholine receptors (α7nAChRs) are essential for anti-inflammatory responses. The human-specific CHRFAM7A gene and its 2bp deletion polymorphism (Δ2bp variant) encodes a structurally-deficient α7nAChRs that may impact the anti-inflammatory function. We studied 45 spinal cord injury (SCI) patients for up to six weeks post SCI to investigate the role of the Δ2bp variant on multiple circulating inflammatory mediators and two outcome measures (neuropathic pain and risk of pressure ulcers). The patient's SCI were classified as either severe or mild. Missing values were imputed. Overall genetic effect was conducted with independent sample t-test and corrected with false discovery rate (FDR). Univariate analysis and regression analysis were applied to evaluate the Δ2bp effects on temporal variation of inflammatory mediators post SCI and their interaction with outcome measures. In severe SCI, the Δ2bp carriers showed higher levels of circulating inflammatory mediators than the Δ2bp non-carriers in TNF-α (FDR = 9.6x10-4), IFN-γ (FDR = 1.3x10-3), IL-13 (FDR = 1.6x10-3), CCL11 (FDR = 2.1x10-3), IL-12p70 (FDR = 2.2x10-3), IL-8 (FDR = 2.2x10-3), CXCL10 (FDR = 3.1x10-3), CCL4 (FDR = 5.7x10-3), IL-12p40 (FDR = 7.1x10-3), IL-1b (FDR = 0.014), IL-15 (FDR = 0.024), and IL-2 (FDR = 0.037). IL-8 and CCL2 were negatively associated with days post injury (DPI) for the Δ2bp carriers (P = 2x10-7 and P = 2x10-8, respectively) and IL-5 was positively associated with DPI for the Δ2bp non-carriers (P = 0.015). Neuropathic pain was marginally positively associated with IL-13 for the Δ2bp carriers (P = 0.056). In mild SCI, the Δ2bp carriers had lower circulating levels of IL-15 (FDR = 0.04) than the Δ2bp non-carriers. Temporal variation of inflammatory mediators post SCI was not associated with the Δ2bp variant. For the mild SCI Δ2bp carriers, risk of pressure ulcers was positively associated with circulating levels of IFN-γ, CXCL10, and CCL4 and negatively associated with circulating levels of IL-12p70. These findings support an important role for the human-specific CHRFAM7A Δ2bp gene variant in modifying anti-inflammatory function of α7nAChRs following SCI.Mingkuan LinWan HuangNadine KabbaniMark M TheissJohn F HamiltonJames M EcklundYvette P ConleyYoram VodovotzDavid BrienzaAmy K WagnerEmily RobbinsGwendolyn A SowaRobert H LipskyPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 5, p e0251110 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Mingkuan Lin Wan Huang Nadine Kabbani Mark M Theiss John F Hamilton James M Ecklund Yvette P Conley Yoram Vodovotz David Brienza Amy K Wagner Emily Robbins Gwendolyn A Sowa Robert H Lipsky Effect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury. |
description |
The α7 neuronal nicotinic acetylcholine receptors (α7nAChRs) are essential for anti-inflammatory responses. The human-specific CHRFAM7A gene and its 2bp deletion polymorphism (Δ2bp variant) encodes a structurally-deficient α7nAChRs that may impact the anti-inflammatory function. We studied 45 spinal cord injury (SCI) patients for up to six weeks post SCI to investigate the role of the Δ2bp variant on multiple circulating inflammatory mediators and two outcome measures (neuropathic pain and risk of pressure ulcers). The patient's SCI were classified as either severe or mild. Missing values were imputed. Overall genetic effect was conducted with independent sample t-test and corrected with false discovery rate (FDR). Univariate analysis and regression analysis were applied to evaluate the Δ2bp effects on temporal variation of inflammatory mediators post SCI and their interaction with outcome measures. In severe SCI, the Δ2bp carriers showed higher levels of circulating inflammatory mediators than the Δ2bp non-carriers in TNF-α (FDR = 9.6x10-4), IFN-γ (FDR = 1.3x10-3), IL-13 (FDR = 1.6x10-3), CCL11 (FDR = 2.1x10-3), IL-12p70 (FDR = 2.2x10-3), IL-8 (FDR = 2.2x10-3), CXCL10 (FDR = 3.1x10-3), CCL4 (FDR = 5.7x10-3), IL-12p40 (FDR = 7.1x10-3), IL-1b (FDR = 0.014), IL-15 (FDR = 0.024), and IL-2 (FDR = 0.037). IL-8 and CCL2 were negatively associated with days post injury (DPI) for the Δ2bp carriers (P = 2x10-7 and P = 2x10-8, respectively) and IL-5 was positively associated with DPI for the Δ2bp non-carriers (P = 0.015). Neuropathic pain was marginally positively associated with IL-13 for the Δ2bp carriers (P = 0.056). In mild SCI, the Δ2bp carriers had lower circulating levels of IL-15 (FDR = 0.04) than the Δ2bp non-carriers. Temporal variation of inflammatory mediators post SCI was not associated with the Δ2bp variant. For the mild SCI Δ2bp carriers, risk of pressure ulcers was positively associated with circulating levels of IFN-γ, CXCL10, and CCL4 and negatively associated with circulating levels of IL-12p70. These findings support an important role for the human-specific CHRFAM7A Δ2bp gene variant in modifying anti-inflammatory function of α7nAChRs following SCI. |
format |
article |
author |
Mingkuan Lin Wan Huang Nadine Kabbani Mark M Theiss John F Hamilton James M Ecklund Yvette P Conley Yoram Vodovotz David Brienza Amy K Wagner Emily Robbins Gwendolyn A Sowa Robert H Lipsky |
author_facet |
Mingkuan Lin Wan Huang Nadine Kabbani Mark M Theiss John F Hamilton James M Ecklund Yvette P Conley Yoram Vodovotz David Brienza Amy K Wagner Emily Robbins Gwendolyn A Sowa Robert H Lipsky |
author_sort |
Mingkuan Lin |
title |
Effect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury. |
title_short |
Effect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury. |
title_full |
Effect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury. |
title_fullStr |
Effect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury. |
title_full_unstemmed |
Effect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury. |
title_sort |
effect of chrfam7a δ2bp gene variant on secondary inflammation after spinal cord injury. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/4a386b81cf444528804f9e1a7194413f |
work_keys_str_mv |
AT mingkuanlin effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT wanhuang effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT nadinekabbani effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT markmtheiss effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT johnfhamilton effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT jamesmecklund effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT yvettepconley effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT yoramvodovotz effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT davidbrienza effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT amykwagner effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT emilyrobbins effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT gwendolynasowa effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury AT roberthlipsky effectofchrfam7ad2bpgenevariantonsecondaryinflammationafterspinalcordinjury |
_version_ |
1718414397059104768 |